The overwhelming prevalent histology was ductal carcinoma (90.6%); 49 patients had luminal subtypes (38.3%), 42 (32.8%) had HER2-positive tumors and 37 women (28.9%) presented with a triple-negative breast cancer. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.